Back
Aptevo Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
51
APVO
Aptevo Therapeutics
Last Price:
10.00
Seasonality Move:
-25.1%
Sell
18
NBY
NovaBay Pharmaceuticals
Last Price:
0.55
Seasonality Move:
-6.61%
Buy
51
Aptevo Therapeutics (APVO)
is a Buy
Is Aptevo Therapeutics a Buy, Sell or Hold?
- The current Aptevo Therapeutics [APVO] share price is $8.70. The Score for APVO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- APVO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APVO Stock Price Chart
What is Aptevo Therapeutics's stock price today?
-
The Aptevo Therapeutics share price today is $8.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APVO is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
APVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 45.25 | Sell |
| Chaikin Money Flow: | -17908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-1.04 - 2.26) | Buy |
| Bollinger Bands (100): | (-0.46 - 1.22) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 35.79 | Sell |
| Chaikin Money Flow: | -12542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.63 - 0.75) | Sell |
| Bollinger Bands (100): | (0.29 - 1.21) | Sell |
APVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.35 | Buy |
| 20-day SMA: | 0.69 | Buy |
| 50-day SMA: | 0.4 | Buy |
| 200-day SMA: | 1.33 | Buy |
| 8-day EMA: | 2.15 | Buy |
| 20-day EMA: | 1.08 | Buy |
| 50-day EMA: | 0.61 | Buy |
| 200-day EMA: | 5.26 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.63 | Sell |
| 20-day SMA: | 0.68 | Sell |
| 50-day SMA: | 0.67 | Sell |
| 200-day SMA: | 2.19 | Sell |
| 8-day EMA: | 0.62 | Sell |
| 20-day EMA: | 0.65 | Sell |
| 50-day EMA: | 0.7 | Sell |
| 200-day EMA: | 5.28 | Sell |
Aptevo Therapeutics Earnings Growth & APVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $95.13 per share, and an increase next year of $1.74 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Aptevo Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||